Cognitive performance and smoking in first-episode psychosis: The self-medication hypothesis

European Archives of Psychiatry and Clinical Neuroscience

Volumn 261, Issue 4, 2011, Pages 241-250

  Segarra, Rafael ^a,b   Zabala, Arantzazu ^b   Eguíluz, Jose Ignacio ^a,b   Ojeda, Natalia ^b,c   Elizagarate, Edorta ^b,d   Sánchez, Pedro ^b,d   Ballesteros, Javier ^b   Gutiérrez, Miguel ^b,e  

^a HOSPITAL DE CRUCES   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c UNIVERSITY OF DEUSTO   (Spain)

^d Osakidetza Basque Health System   (Spain)

^e HOSPITAL TXAGORRITXU   (Spain)

Author keywords

Cigarette smoking; Cognitive deficits; First episode psychosis; Nicotine; Self medication

Indexed keywords

OLANZAPINE; RISPERIDONE;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BIPOLAR DISORDER; BRIEF PSYCHOTIC DISORDER; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; DELUSION; DELUSIONAL DISORDER; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FIRST EPISODE PSYCHOSIS; HALLUCINATION; HUMAN; MALE; MENTAL DISEASE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SELECTIVE ATTENTION; SELF MEDICATION; SMOKING HABIT; THOUGHT DISORDER; TREATMENT DURATION; WORKING MEMORY;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; ATTENTION; COGNITION DISORDERS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SELF REPORT; SMOKING; TIME FACTORS; YOUNG ADULT;

EID: 79960219178     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-010-0146-6     Document Type: Article

References (46)

1. LE Adler LD Hoffer A Wiser R Freedman 1993 Normalization of auditory physiology by cigarette smoking in schizophrenic patients Am J Psychiatry 150 12 1856 1861 8238642 1:STN:280:DyaK2c%2FlslWitA%3D%3D (Pubitemid 23356580)
2. LE Adler LJ Hoffer J Griffith MC Waldo R Freedman 1992 Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics Biol Psychiatry 32 7 607 616 1450287 10.1016/0006-3223(92)90073-9 1:STN:280:DyaK3s%2FotFKitg%3D%3D
3. LE Adler A Olincy M Waldo JG Harris J Griffith K Stevens K Flach H Nagamoto P Bickford S Leonard R Freedman 1998 Schizophrenia, sensory gating, and nicotinic receptors Schizophr Bull 24 2 189 202 9613620 1:STN:280: DyaK1c3ntlKktA%3D%3D (Pubitemid 28404980)
4. MC Aguilar M Gurpegui FJ Diaz J de Leon 2005 Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions Br J Psychiatry 186 215 221 15738502 10.1192/bjp.186.3.215 (Pubitemid 40343815)
5. CG AhnAllen PG Nestor ME Shenton RW McCarley MA Niznikiewicz 2008 Early nicotine withdrawal and transdermal nicotine effects on neurocognitive performance in schizophrenia Schizophr Res 100 1-3 261 269 17884348 10.1016/j.schres.2007.07.030 (Pubitemid 351324859)
6. MT Avila JD Sherr E Hong CS Myers GK Thaker 2003 Effects of nicotine on leading saccades during smooth pursuit eye movements in smokers and nonsmokers with schizophrenia Neuropsychopharmacology 28 12 2184 2191 12968127 1:CAS:528:DC%2BD3sXptFOrurw%3D (Pubitemid 37468186)
7. RS Barr MA Culhane LE Jubelt RS Mufti MA Dyer AP Weiss T Deckersbach JF Kelly O Freudenreich DC Goff AE Evins 2008 The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls Neuropsychopharmacology 33 480 490 17443126 10.1038/sj.npp.1301423 1:CAS:528:DC%2BD1cXmsFSluw%3D%3D
8. S Beratis A Katrivanou P Gourzis 2001 Factors affecting smoking in schizophrenia Compr Psychiatry 42 5 393 402 11559866 10.1053/comp.2001.26273 1:STN:280:DC%2BD3MrhtFOhtw%3D%3D (Pubitemid 32884847)
9. WJ Brewer SJ Wood LJ Phillips SM Francey C Pantelis AR Yung B Cornblatt PD McGorry 2006 Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis Schizophr Bull 32 3 538 555 16782759 10.1093/schbul/sbj077 (Pubitemid 43992327)
10. JA Carrillo AG Herraiz SI Ramos G Gervasini S Vizcaino J Benitez 2003 Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine J Clin Psychopharmacol 23 2 119 127 12640212 10.1097/00004714-200304000-00003 1:CAS:528:DC%2BD3sXitFGlsr0%3D (Pubitemid 36368788)
11. M Davidson S Galderisi M Weiser N Werbeloff WW Fleischhacker RS Keefe H Boter IP Keet D Prelipceanu JK Rybakowski J Libiger M Hummer S Dollfus JJ Lopez-Ibor LG Hranov W Gaebel J Peuskens N Lindefors A Riecher-Rossler RS Kahn 2009 Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST) Am J Psychiatry 166 6 675 682 19369319 10.1176/appi.ajp.2008.08060806
12. J de Leon FJ Diaz 2005 A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors Schizophr Res 76 2-3 135 157 15949648 10.1016/j.schres.2005.02.010 (Pubitemid 40812332)
13. J de Leon FJ Diaz MC Aguilar D Jurado M Gurpegui 2006 Does smoking reduce akathisia? Testing a narrow version of the self-medication hypothesis Schizophr Res 86 1-3 256 268 16814524 10.1016/j.schres.2006.05.009 (Pubitemid 44234048)
14. L Depatie GA O'Driscoll AL Holahan V Atkinson JX Thavundayil NN Kin S Lal 2002 Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study Neuropsychopharmacology 27 6 1056 1070 12464463 10.1016/S0893-133X(02)00372-X 1:CAS:528:DC%2BD38XptFKisLw%3D (Pubitemid 35447643)
15. A Dervaux X Laqueille 2007 Tobacco and schizophrenia: therapeutic aspects Encephale 33 4 Pt 1 629 632 18033154 10.1016/S0013-7006(07)92064-3 1:STN:280:DC%2BD2snps1Wktw%3D%3D
16. A Dervaux X Laqueille 2008 Smoking and schizophrenia: epidemiological and clinical features Encephale 34 3 299 305 18558153 10.1016/j.encep.2007.04.003 1:STN:280:DC%2BD1cvps1Cntw%3D%3D
17. U Ettinger SC Williams D Patel TM Michel A Nwaigwe A Caceres MA Mehta AP Anilkumar V Kumari 2009 Effects of acute nicotine on brain function in healthy smokers and non-smokers: estimation of inter-individual response heterogeneity Neuroimage 45 2 549 561 19159693 10.1016/j.neuroimage.2008.12.029
18. First M, Spittzer R, Gibbon M, Williams J (1995) Structured clinical interview for DSM-IV axis I disorders, patient ediction (SCID-P). Version 2. N. Y. S. P. Institute, Biometrics Research, New York
19. R Freedman H Coon M Myles-Worsley A Orr-Urtreger A Olincy A Davis M Polymeropoulos J Holik J Hopkins M Hoff J Rosenthal MC Waldo F Reimherr P Wender J Yaw DA Young CR Breese C Adams D Patterson LE Adler L Kruglyak S Leonard W Byerley 1997 Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus Proc Natl Acad Sci U S A 94 2 587 592 9012828 10.1073/pnas.94.2.587 1:CAS:528:DyaK2sXnslGktA%3D%3D (Pubitemid 27053677)
20. TP George JC Vessicchio A Termine DM Sahady CA Head WT Pepper TR Kosten BE Wexler 2002 Effects of smoking abstinence on visuospatial working memory function in schizophrenia Neuropsychopharmacology 26 1 75 85 11751034 10.1016/S0893-133X(01)00296-2 (Pubitemid 34075278)
21. JG Harris S Kongs D Allensworth L Martin J Tregellas B Sullivan G Zerbe R Freedman 2004 Effects of nicotine on cognitive deficits in schizophrenia Neuropsychopharmacology 29 7 1378 1385 15138435 10.1038/sj.npp.1300450 1:CAS:528:DC%2BD2cXkvFWltLw%3D (Pubitemid 38780661)
22. SB Hutton U Ettinger 2006 The antisaccade task as a research tool in psychopathology: a critical review Psychophysiology 43 3 302 313 16805870 10.1111/j.1469-8986.2006.00403.x (Pubitemid 43927348)
23. A Imperato MC Obinu MA Casu MS Mascia L Dazzi GL Gessa 1993 Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors J Pharmacol Exp Ther 266 2 557 562 8102643 1:CAS:528:DyaK2cXksFKktA%3D%3D (Pubitemid 23318661)
24. LK Jacobsen DC D'Souza WE Mencl KR Pugh P Skudlarski JH Krystal 2004 Nicotine effects on brain function and functional connectivity in schizophrenia Biol Psychiatry 55 8 850 858 15050867 10.1016/j.biopsych.2003.12.023 1:CAS:528:DC%2BD2cXisF2isLo%3D (Pubitemid 38429877)
25. RS Keefe RM Bilder SM Davis PD Harvey BW Palmer JM Gold HY Meltzer MF Green G Capuano TS Stroup JP McEvoy MS Swartz RA Rosenheck DO Perkins CE Davis JK Hsiao JA Lieberman 2007 Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial Arch Gen Psychiatry 64 6 633 647 17548746 10.1001/archpsyc.64.6.633 1:CAS:528:DC%2BD2sXntlOgtLk%3D (Pubitemid 46878665)
26. RS Keefe JA Sweeney H Gu RM Hamer DO Perkins JP McEvoy JA Lieberman 2007 Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison Am J Psychiatry 164 7 1061 1071 17606658 10.1176/appi.ajp.164.7.1061 (Pubitemid 47121395)
27. C Kelly RG McCreadie 1999 Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland Am J Psychiatry 156 11 1751 1757 10553739 1:STN:280:DC%2BD3c%2FhvFWltQ%3D%3D (Pubitemid 29517568)
28. V Kumari P Postma 2005 Nicotine use in schizophrenia: the self medication hypotheses Neurosci Biobehav Rev 29 6 1021 1034 15964073 10.1016/j.neubiorev. 2005.02.006 1:CAS:528:DC%2BD2MXntVGhtr0%3D (Pubitemid 41097398)
29. S Leonard J Gault J Hopkins J Logel R Vianzon M Short C Drebing R Berger D Venn P Sirota G Zerbe A Olincy RG Ross LE Adler R Freedman 2002 Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia Arch Gen Psychiatry 59 12 1085 1096 12470124 10.1001/archpsyc.59.12.1085 1:CAS:528:DC%2BD38XpslejsL4%3D (Pubitemid 35424018)
30. ED Levin W Wilson JE Rose J McEvoy 1996 Nicotine-haloperidol interactions and cognitive performance in schizophrenics Neuropsychopharmacology 15 5 429 436 8914115 10.1016/S0893-133X(96)00018-8 1:CAS:528:DyaK28XmvFWkt7g%3D (Pubitemid 26389866)
31. JA Lieberman JA Javitch H Moore 2008 Cholinergic agonists as novel treatments for schizophrenia: the promise of rational drug development for psychiatry Am J Psychiatry 165 8 931 936 18676593 10.1176/appi.ajp.2008.08050769
32. O Lingjaerde UG Ahlfors P Bech SJ Dencker K Elgen 1987 The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients Acta Psychiatr Scand Suppl 334 1 100 2887090 10.1111/j.1600-0447.1987.tb10566.x 1:STN:280:DyaL2s3psFemsQ%3D%3D (Pubitemid 17115352)
33. HD Mansvelder KI van Aerde JJ Couey AB Brussaard 2006 Nicotinic modulation of neuronal networks: from receptors to cognition Psychopharmacology (Berl) 184 3-4 292 305 10.1007/s00213-005-0070-z 1:CAS:528:DC%2BD28XhsFCls7c%3D (Pubitemid 43255846)
34. A Marutle X Zhang J Court M Piggott M Johnson R Perry E Perry A Nordberg 2001 Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia J Chem Neuroanat 22 1-2 115 126 11470559 10.1016/S0891-0618(01) 00117-X 1:CAS:528:DC%2BD3MXltlOjtb0%3D (Pubitemid 32695514)
35. SA Montgomery M Asberg 1979 A new depression scale designed to be sensitive to change Br J Psychiatry 134 382 389 444788 10.1192/bjp.134.4.382 1:STN:280:DyaE1M7ovVCksg%3D%3D (Pubitemid 9136500)
36. CS Myers O Robles AN Kakoyannis JD Sherr MT Avila TA Blaxton GK Thaker 2004 Nicotine improves delayed recognition in schizophrenic patients Psychopharmacology (Berl) 174 3 334 340 10.1007/s00213-003-1764-8 1:CAS:528:DC%2BD2cXls1antrs%3D (Pubitemid 39044291)
37. A Olincy LL Johnson RG Ross 2003 Differential effects of cigarette smoking on performance of a smooth pursuit and a saccadic eye movement task in schizophrenia Psychiatry Res 117 3 223 236 12686365 10.1016/S0165-1781(03)00022- 2 (Pubitemid 36398498)
38. V Peralta M Cuesta 1994 Validación de la escala de los síndromes positivo y negativo (PANSS) en una muestra de esquizofrénicos españoles Actas Luso-Esp Neurol Psiquiatr 22 4 171 177
39. KA Sacco A Termine A Seyal MM Dudas JC Vessicchio S Krishnan-Sarin PI Jatlow BE Wexler TP George 2005 Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms Arch Gen Psychiatry 62 6 649 659 15939842 10.1001/archpsyc.62.6.649 (Pubitemid 40973440)
40. JD Sherr C Myers MT Avila A Elliott TA Blaxton GK Thaker 2002 The effects of nicotine on specific eye tracking measures in schizophrenia Biol Psychiatry 52 7 721 728 12372663 10.1016/S0006-3223(02)01342-2 1:CAS:528: DC%2BD38Xns1Sjs7s%3D
41. GM Simpson JW Angus 1970 A rating scale for extrapyramidal side effects Acta Psychiatr Scand Suppl 212 11 19 4917967 10.1111/j.1600-0447.1970.tb02066.x 1:STN:280:DyaE3c3ptFWjuw%3D%3D
42. RC Smith A Singh M Infante A Khandat A Kloos 2002 Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia Neuropsychopharmacology 27 3 479 497 12225705 10.1016/S0893- 133X(02)00324-X 1:CAS:528:DC%2BD38XmvVWqsLk%3D (Pubitemid 35253795)
43. RC Smith J Warner-Cohen M Matute E Butler E Kelly S Vaidhyanathaswamy A Khan 2006 Effects of nicotine nasal spray on cognitive function in schizophrenia Neuropsychopharmacology 31 3 637 643 16160711 10.1038/sj.npp.1300881 1:CAS:528:DC%2BD28XhsVKqur8%3D (Pubitemid 43276979)
44. D Wade S Harrigan J Edwards PM Burgess G Whelan PD McGorry 2006 Course of substance misuse and daily tobacco use in first-episode psychosis Schizophr Res 81 2-3 145 150 16298107 10.1016/j.schres.2005.09.010 (Pubitemid 43107688)
45. M Weiser A Reichenberg I Grotto R Yasvitzky J Rabinowitz G Lubin D Nahon HY Knobler M Davidson 2004 Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study Am J Psychiatry 161 7 1219 1223 15229054 10.1176/appi.ajp.161.7.1219 (Pubitemid 38859171)
46. A Zabala JI Eguiluz R Segarra S Enjuto J Ezcurra AG Pinto M Gutierrez 2009 Cognitive performance and cigarette smoking in first-episode psychosis Eur Arch Psychiatry Clin Neurosci 259 2 65 71 18584231 10.1007/s00406-008-0835-6